Design Considerations and Requirements for In-Flight Refueling of Unmanned Vehicles

The need to refuel in-flight has become a significant part of military strategy for air forces to work at further distances from safe shores. The use of Unmanned Vehicles is increasing and expected to be the principal part of military deployment. This paper will address the concepts and requirements for applying refueling unmanned vehicles in a military context for supporting fixed and rotor aircraft. Design aspects of human factors in the process are considered, reviewed and solutions proposed to allow for the first generation of designs to be developed. Furthermore, the practical and operational limitations will be addressed as part of the human factors implications. Finally, the design parameters are proposed for the first stage developments to achieve Unmanned Vehicle refueling

Propeller Design Requirements for Quadcopters Utilizing Variable Pitch Propellers

Unmanned aerial vehicles, UAV, has increases in the drastically in these past several years since their costs reduced. This research is based and built upon previous research presented in a conference. With the advent of commercial Quadcopters, four propeller systems, are used, being designed and used to operate the advantages of both flight and hovering. The basic design of their propeller blades has not evolved from the early days of manned flight when wooden fixed blades were used. In this paper that expands upon previous findings and discussions it explores the historical developments. Furthermore, how the expansion and reduction in costs of modern materials and manufacturing techniques that offer more accurate matching of blades’ needs and applications

Take-off Characteristics for NACA 4612 Aerofoil in a Twin-Wing Configuration With Optimum Angles of Attack

Unmanned Aerial Vehicles are used generally at low levels and speeds. The research reported in this article investigates the possible use of twin-wing designs for higher altitudes with a focus on the possible lift capable for either short runways or high payloads. The wing aerofoil and unique Angles of Attack, AoA, are set 5o on the upper wing and 10o on the lower. There is a positive upper wing stagger of 50% of the chord length at height separation of 1 chord. These parameters have been established from previous research and this research investigates how they generate lift at take-off and what lift and drag properties exist. It also determines if these parameters are in-line with those for high altitude flight

Multi-Choice Questions and Their Problems When Used for Assessment of Aircraft Engineers Education

Licensed aircraft engineers under the European Aviation Safety Agency, EASA, undertake academic training to complement their practical and type specific studies. These exams are mainly Multi-Choice Questions, MCQ, and four 20-minute essays. The MCQ exams are as few as 16 questions to a maximum of 140 questions. A score of 75% is needed to pass each exam, and each question has three possible answers. This authors of this paper reviews the theory and design of the MCQ and asks if the assumptions are valid and that it achieves the academic level assumed for engineers who will be maintaining some of the most complex system in the world, and the safety of passengers. It will argue that there are failings and how this can be address, in particular, that repeated tests should have a higher pass level

WholeTree Substrate and Fertilizer Rate in Production of Greenhouse-grown Petunia (Petunia ×hybrida Vilm.) and Marigold (Tagetes patula L.)

A substrate component (WholeTree) made from loblolly pine (Pinus taeda L.) was evaluated along with starter fertilizer rate in the production of greenhouse-grown petunia (Petunia ×hybrida Vilm. ‘Dreams Purple’) and marigold (Tagetes patula L. ‘Hero Spry’). Loblolly pine from a 12-year-old plantation were harvested at ground level, chipped, and further processed through a hammer mill to pass a 0.64-cm screen. The resulting WholeTree (WT) substrate was used alone or combined with 20% (WTP2) or 50% (WTP5) (by volume) Canadian sphagnum peatmoss and compared with an industry standard peat-lite (PL) mix of 8 peatmoss : 1 vermiculite : 1 perlite (by volume). Substrates were amended with 1.78 kg·m−3 dolomitic lime, 0.59 kg·m−3 gypsum [CaSO4-2(H2O)], 0.44 kg·m−3 Micromax, 1.78 kg·m−3 16N–2.6P–9.9K (3- to 4-month release), and 1.78 kg·m−3 16N–2.6P–10.8K (5- to 6-month release). A 7N–1.3P–8.3K starter fertilizer (SF) was added to each substrate at 0.0, 1.19, 2.37, or 3.56 kg·m−3. Container capacity (CC) was greatest for PL and decreased as the percentage of peatmoss in the substrate decreased with WT having 35% less CC than PL. Conversely, air space (AS) was greatest for the WT and decreased as percentage of peatmoss increased with PL containing 33% less AS than WT. In general, petunia dry weight was greatest for any substrate containing peatmoss with a SF rate of 2.37 kg·m−3 or greater. The exception was that petunia grown in WT at 3.56 kg·m−3 SF had similar dry weight as all other treatments. Marigold dry weight was similar for all substrates where at least 2.37 kg·m−3 SF was used

Improving bone properties and fracture susceptibility: experimental models of genetic manipulation, pharmacologic intervention, and cellular perturbation reveal new approaches for improving bone health

poster abstractBone, a crucial support structure in the human body, is often taken for granted for its lightweight properties and unparalleled strength. Skeletal fracture is a major clinical condition affecting millions of Americans, which results from abnormal aging, hormonal imbalance, genetic conditions, and lifestyle choices (e.g., exercise). Because fractures are caused by a number of different factors, reducing fracture incidence requires a multifactorial approach to unraveling the underlying biology of bone metabolism, in order to discover new ways to improve bone properties and prevent fractures. We have taken such an approach by conducting (1) genetic manipulation experiments in mice, where genes predicted to be involved in bone mass regulation were mutated; (2) pharmacologic experiments to quantify the dose-response effect of an agent that inhibits bone loss, and (3) cell culture experiments, aimed at revealing molecular pathways activated by mechanical stimulation. METHODS: Mice with mutations in two genes, likely to regulate bone mass (SOST, DKK1) were generated and subjected to in vivo dual energy x-ray absorptiometry (DEXA) scans at 6-wk old. Whole body scans were analyzed for bone mineral density (BMD) using Lunar Piximus II v2.10 software. Mice (6-wk) were also dosed (0, 1, 10, 100, or 1000 mg/kg) with daily alendronate HCl, a bisphosphonate that inhibits osteoclast activity. Six wks later, the mice were sacrificed, and the femurs were dissected and sectioned for histological analysis of bone formation parameters, including mineralizing surface (MS/BS), mineral apposition rate (MAR), and bone formation rate (BFR/BS). To understand the cellular signaling events in response to mechanical loading, bone marrow mesenchymal stem cells (MSCs) were treated with 10, 20, 30, or 40μM PF7408671, an S6 kinase inhibitor. Cells then were subject to 100 cycles of biaxial mechanical strain (2%, 10 cycles/min). Protein lysates were separated by electrophoresis and probed for phosphorylation of Rictor and Akt by Western blot. RESULTS: Mice harboring mutations in either the SOST gene or the DKK1gene exhibited significantly increased BMD compared to wild-type control mice, though the SOST mutation had a stronger effect on BMD than DKK1. Mice with compound mutations (SOST and DKK1 mutations) had significantly greater BMD than mice with either single mutation, suggesting that inhibition of SOST and DKK1 might be an effective means to increase bone mass in patients susceptible to fracture. Mice treated with high-dose alendronate (100 or 1,000 mg/kg) exhibited significant decreases in bone formation parameters (MS/BS, MAR, and BFR/BS) compared to untreated (0 mg) mice, suggesting that while this compound might be beneficial for inhibiting bone loss, it also inhibits bone formation. The signaling hub, mTORC2, is a critical regulator of mechanical force in MSC progenitors. Our data demonstrate that S6 kinase is an upstream activator of mTORC2 in response to mechanical strain. CONCLUSION: Our experiments suggest that genetic manipulation of mice reveal viable protein targets (e.g., SOST, DKK1) that could ultimately be manipulated pharmacologically to improve bone mass. We also found that an FDA-approved class of drugs inhibits bone formation even at very low doses, suggesting that additional pro-anabolic compounds might benefit patients taking bisphosphonates. On a cell signaling level, we found that the mTORC2 pathway shows considerable promise for pharmacologic manipulation to simulate the effects of exercise. Taken together, these experiments highlight the utility of a broad approach to solving bone metabolism challenges that can affect fracture susceptibility

Propranolol Sensitizes Vascular Sarcoma Cells to Doxorubicin by Altering Lysosomal Drug Sequestration and Drug Efflux

Angiosarcoma is a rare cancer of blood vessel–forming cells with a high patient mortality and few treatment options. Although chemotherapy often produces initial clinical responses, outcomes remain poor, largely due to the development of drug resistance. We previously identified a subset of doxorubicin-resistant cells in human angiosarcoma and canine hemangiosarcoma cell lines that exhibit high lysosomal accumulation of doxorubicin. Hydrophobic, weak base chemotherapeutics, like doxorubicin, are known to sequester within lysosomes, promoting resistance by limiting drug accessibility to cellular targets. Drug synergy between the beta adrenergic receptor (β-AR) antagonist, propranolol, and multiple chemotherapeutics has been documented in vitro, and clinical data have corroborated the increased therapeutic potential of propranolol with chemotherapy in angiosarcoma patients. Because propranolol is also a weak base and accumulates in lysosomes, we sought to determine whether propranolol enhanced doxorubicin cytotoxicity via antagonism of β-ARs or by preventing the lysosomal accumulation of doxorubicin. β-AR-like immunoreactivities were confirmed in primary tumor tissues and cell lines; receptor function was verified by monitoring downstream signaling pathways of β-ARs in response to receptor agonists and antagonists. Mechanistically, propranolol increased cytoplasmic doxorubicin concentrations in sarcoma cells by decreasing the lysosomal accumulation and cellular efflux of this chemotherapeutic agent. Equivalent concentrations of the receptor-active S-(−) and -inactive R-(+) enantiomers of propranolol produced similar effects, supporting a β-AR-independent mechanism. Long-term exposure of hemangiosarcoma cells to propranolol expanded both lysosomal size and number, yet cells remained sensitive to doxorubicin in the presence of propranolol. In contrast, removal of propranolol increased cellular resistance to doxorubicin, underscoring lysosomal doxorubicin sequestration as a key mechanism of resistance. Our results support the repurposing of the R-(+) enantiomer of propranolol with weak base chemotherapeutics to increase cytotoxicity and reduce the development of drug-resistant cell populations without the cardiovascular and other side effects associated with antagonism of β-ARs